Voraxaze
Payments companies reported to CMS as associated with Voraxaze. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Voraxaze, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Voraxaze
These are the largest totals companies reported as associated with Voraxaze. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Scott Howard | Memphis, TN | Pediatric Hematology-Oncology | $71,360.16 |
| Jaya Kala | Houston, TX | Nephrology (Internal Medicine) | $30,016.78 |
| Anish Ray | Fort Worth, TX | Pediatric Hematology-Oncology | $24,027.77 |
| Charles Minn | Tacoma, WA | Nephrology (Internal Medicine) | $14,808.90 |
| Shruti Gupta | Boston, MA | Internal Medicine | $6,490.00 |
| Anitha Varghese | Stafford, TX | Gerontology (Nurse Practitioner) | $4,710.75 |
| Lauren Schaff | New York, NY | Neurology (Psychiatry & Neurology) | $4,228.81 |
| Gordon Bernard | Nashville, TN | Critical Care Medicine (Internal Medicine) | $3,500.00 |
| Liza Squires | Chester Springs, PA | $3,000.00 | |
| Joe Mendez | Salt Lake City, UT | Neurological Surgery | $1,428.71 |
Prescribed Voraxaze?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.